• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病与慢性肾脏病及终末期肾病发病风险:一项系统评价与荟萃分析

Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis.

作者信息

Ungprasert Patompong, Raksasuk Sukit

机构信息

Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Road, Bangkoknoi, Bangkok, 10700, Thailand.

Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Int Urol Nephrol. 2018 Jul;50(7):1277-1283. doi: 10.1007/s11255-018-1868-z. Epub 2018 Apr 11.

DOI:10.1007/s11255-018-1868-z
PMID:29644523
Abstract

OBJECTIVES

Patients with psoriasis may have a higher risk of developing chronic kidney (CKD) and end-stage renal disease (ESRD) compared with general population. This systematic review and meta-analysis aimed to comprehensively investigate this association by reviewing all available evidence.

METHODS

A systematic review was performed using MEDLINE and EMBASE database from inception to January 2018 to identify all cohort studies that compared the risk of incident CKD and/or ESRD in patients with psoriasis versus individuals without psoriasis. Pooled risk ratio and 95% confidence interval were calculated using random-effect, generic inverse variance method.

RESULTS

A total of four retrospective cohort studies with 199,808 patients with psoriasis were included. The risk of incident CKD and ESRD was significantly increased among patients with psoriasis with the pooled risk ratio of 1.34 (95% CI, 1.14-1.57) and 1.29 (95% CI, 1.05-1.60), respectively.

CONCLUSION

A significantly increased risk of incident CKD and ESRD among patients with psoriasis compared with individuals without psoriasis was demonstrated in this study.

摘要

目的

与普通人群相比,银屑病患者发生慢性肾脏病(CKD)和终末期肾病(ESRD)的风险可能更高。本系统评价和荟萃分析旨在通过回顾所有现有证据全面研究这种关联。

方法

使用MEDLINE和EMBASE数据库进行系统评价,检索从建库至2018年1月的所有队列研究,以比较银屑病患者与非银屑病患者发生CKD和/或ESRD的风险。采用随机效应、通用逆方差法计算合并风险比和95%置信区间。

结果

共纳入4项回顾性队列研究,涉及199,808例银屑病患者。银屑病患者发生CKD和ESRD的风险显著增加,合并风险比分别为1.34(95%CI,1.14 - 1.57)和1.29(95%CI,1.05 - 1.60)。

结论

本研究表明,与非银屑病患者相比,银屑病患者发生CKD和ESRD的风险显著增加。

相似文献

1
Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis.银屑病与慢性肾脏病及终末期肾病发病风险:一项系统评价与荟萃分析
Int Urol Nephrol. 2018 Jul;50(7):1277-1283. doi: 10.1007/s11255-018-1868-z. Epub 2018 Apr 11.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
3
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.非酒精性脂肪性肝病增加了慢性肾脏病发病的风险:系统评价和荟萃分析。
Metabolism. 2018 Feb;79:64-76. doi: 10.1016/j.metabol.2017.11.003. Epub 2017 Nov 11.
4
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
5
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
6
The impact of change of renal replacement therapy modality on sleep quality in patients with end-stage renal disease: a systematic review and meta-analysis.改变肾脏替代治疗方式对终末期肾病患者睡眠质量的影响:系统评价和荟萃分析。
J Nephrol. 2018 Feb;31(1):61-70. doi: 10.1007/s40620-017-0409-7. Epub 2017 Jun 1.
7
Antiplatelet agents for chronic kidney disease.抗血小板药物在慢性肾脏病中的应用。
Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD008834. doi: 10.1002/14651858.CD008834.pub4.
8
Prevalence and Associated Factors of Frailty and Mortality in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Systematic Review and Meta-Analysis.接受血液透析的终末期肾病患者衰弱和死亡的患病率及相关因素:一项系统评价和荟萃分析
Int J Environ Res Public Health. 2021 Mar 27;18(7):3471. doi: 10.3390/ijerph18073471.
9
Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis.心房颤动与心源性猝死相关:一项系统评价和荟萃分析。
J Interv Card Electrophysiol. 2018 Mar;51(2):91-104. doi: 10.1007/s10840-017-0308-9. Epub 2018 Jan 13.
10
Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.载脂蛋白 L1 基因变异与 HIV 患者的肾脏疾病:系统评价和荟萃分析。
J Nephrol. 2023 May;36(4):1119-1134. doi: 10.1007/s40620-022-01512-9. Epub 2022 Dec 13.

引用本文的文献

1
Diabetes is associated with a poor prognosis in patients with psoriasis and coronary artery disease.糖尿病与银屑病和冠状动脉疾病患者的不良预后相关。
BMC Endocr Disord. 2025 Jul 14;25(1):174. doi: 10.1186/s12902-025-01996-z.
2
Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches.通过整合分子对接、单支持向量机算法和分子动力学模拟方法,将美国食品药品监督管理局(FDA)批准的药物用于银屑病适应症的重新利用。
Sci Rep. 2025 Jul 1;15(1):21211. doi: 10.1038/s41598-025-01448-7.
3
Clinicopathological features and renal outcomes in patients with IgA nephropathy secondary to psoriasis.

本文引用的文献

1
Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.银屑病患者生物治疗的主要不良心血管事件风险评估
J Drugs Dermatol. 2017 Oct 1;16(10):1002-1013.
2
High prevalence of alcohol use disorders in patients with inflammatory skin diseases applies to both psoriasis and eczema.炎症性皮肤病患者中酒精使用障碍的高患病率在银屑病和湿疹患者中均有体现。
Br J Dermatol. 2017 Sep;177(3):606-607. doi: 10.1111/bjd.15674.
3
Psoriasis and risk of incident atrial fibrillation: A systematic review and meta-analysis.
银屑病继发IgA肾病患者的临床病理特征及肾脏预后
Clin Exp Med. 2025 Jun 17;25(1):207. doi: 10.1007/s10238-025-01750-8.
4
A Novel Immune-Related Three-Gene Signature and Immune Infiltration Insights in Psoriasis and Chronic Kidney Disease.银屑病和慢性肾脏病中一种新型免疫相关三基因特征及免疫浸润见解
Clin Cosmet Investig Dermatol. 2025 Jan 25;18:267-286. doi: 10.2147/CCID.S499202. eCollection 2025.
5
Interleukin-23 versus Interleukin-17 Inhibitors in Preventing Incidental Psoriatic Arthritis in Patients with Psoriasis: A Real-World Comparison From the TriNetX US Collaborative Network.白细胞介素-23抑制剂与白细胞介素-17抑制剂预防银屑病患者并发银屑病关节炎的疗效比较:来自TriNetX美国协作网络的真实世界研究
BioDrugs. 2025 Mar;39(2):297-306. doi: 10.1007/s40259-025-00705-5. Epub 2025 Jan 29.
6
Investigation of clinical and subclinical renal damage in Psoriasis.银屑病患者临床及亚临床肾损伤的研究
Arch Dermatol Res. 2024 Dec 12;317(1):104. doi: 10.1007/s00403-024-03592-y.
7
Role of Vitamin C on methotrexate-induced nephrotoxicity in psoriasis context: A preclinical assessment.维生素C在银屑病背景下对甲氨蝶呤诱导的肾毒性中的作用:一项临床前评估。
Toxicol Rep. 2024 Oct 21;13:101782. doi: 10.1016/j.toxrep.2024.101782. eCollection 2024 Dec.
8
Unveiling the genetic link and pathogenesis between psoriasis and IgA nephropathy based on Mendelian randomization and transcriptome data analyses.基于孟德尔随机化和转录组数据分析揭示银屑病和 IgA 肾病之间的遗传关联和发病机制。
Arch Dermatol Res. 2024 Oct 26;316(10):717. doi: 10.1007/s00403-024-03465-4.
9
Association between psoriasis and asthma: a systematic review and bidirectional meta-analysis.银屑病与哮喘的相关性:系统评价和双向荟萃分析。
BMC Pulm Med. 2024 Jun 24;24(1):293. doi: 10.1186/s12890-024-03078-7.
10
Managing the Patient with Psoriasis and Metabolic Comorbidities.管理合并代谢性合并症的银屑病患者。
Am J Clin Dermatol. 2024 Jul;25(4):527-540. doi: 10.1007/s40257-024-00857-0. Epub 2024 May 15.
银屑病与新发房颤风险:一项系统评价和荟萃分析。
Indian J Dermatol Venereol Leprol. 2016 Sep-Oct;82(5):489-97. doi: 10.4103/0378-6323.186480.
4
Psoriasis and Cardiovascular Disease.银屑病与心血管病。
Med Clin North Am. 2015 Nov;99(6):1227-42. doi: 10.1016/j.mcna.2015.08.001. Epub 2015 Sep 12.
5
Obesity: a key component of psoriasis.肥胖:银屑病的一个关键组成部分。
Acta Biomed. 2015 Sep 14;86(2):121-9.
6
Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink.银屑病与重大心血管事件风险:使用临床实践研究数据链的队列研究
J Invest Dermatol. 2015 Sep;135(9):2189-2197. doi: 10.1038/jid.2015.87. Epub 2015 Mar 5.
7
Psoriasis-associated IgA nephropathy under infliximab therapy.英夫利昔单抗治疗下的银屑病相关IgA肾病
Int J Dermatol. 2015 Mar;54(3):e79-80. doi: 10.1111/ijd.12622. Epub 2014 Dec 16.
8
Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study.银屑病严重程度、合并用药及合并症与肾小球肾炎和慢性肾脏病风险增加的关系:一项全国基于人群的队列研究。
Br J Dermatol. 2015 Jul;173(1):146-54. doi: 10.1111/bjd.13599. Epub 2015 May 12.
9
Prevalence and characteristics of metabolic syndrome in South-East Asian psoriatic patients: a case-control study.东南亚银屑病患者代谢综合征的患病率及特征:一项病例对照研究。
J Dermatol. 2014 Oct;41(10):898-902. doi: 10.1111/1346-8138.12614. Epub 2014 Sep 9.
10
Psoriasis and risk of venous thromboembolism: a systematic review and meta-analysis.银屑病与静脉血栓栓塞风险:系统评价和荟萃分析。
QJM. 2014 Oct;107(10):793-7. doi: 10.1093/qjmed/hcu073. Epub 2014 Apr 8.